Jacqueline Bohn to Cost-Benefit Analysis
This is a "connection" page, showing publications Jacqueline Bohn has written about Cost-Benefit Analysis.
Connection Strength
0.476
-
Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis. Int J Gynecol Cancer. 2022 02; 32(2):133-140.
Score: 0.192
-
Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis. Obstet Gynecol. 2021 10 01; 138(4):557-564.
Score: 0.190
-
Hysterectomy with a general gynecologist vs gynecologic-oncologist in the setting of endometrial intraepithelial neoplasia: a cost-effectiveness analysis. Am J Obstet Gynecol. 2022 10; 227(4):609.e1-609.e8.
Score: 0.050
-
Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis. Gynecol Oncol. 2021 01; 160(1):214-218.
Score: 0.044